Doug Schenkel Joins Delfi Diagnostics as Chief Financial Officer
/PRNewswire/ -- Delfi Diagnostics, a pioneering developer of a new class of high-performance, affordable liquid biopsy tests for early cancer detection,...
Stay updated with breaking news from Delfi Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Delfi Diagnostics, a pioneering developer of a new class of high-performance, affordable liquid biopsy tests for early cancer detection,...
A novel artificial intelligence blood testing technology developed by researchers at the Johns Hopkins Kimmel Cancer Center was found to detect over 90% of lung cancers in samples from nearly 800 individuals with and without cancer.
Industry Leaders Tara Maddala and Allison Ryan Join Delfi Diagnostics Leadership Team News provided by Share this article Share this article BALTIMORE, Feb. 17, 2021 /PRNewswire/ -- Delfi Diagnostics, a pioneering developer of a new class of high performance, affordable liquid biopsy tests for early cancer detection, has hired Tara Maddala as Vice President of Clinical Development and Allison Ryan as Vice President of Data Science. They each will be responsible for establishing critical new functions within the company as it works to develop and commercialize Delfi's cancer screening blood te...